| # | Side effect | Count |
|---|---|---|
| 0 | CONDITION AGGRAVATED | 45 |
| 1 | RESPIRATORY FAILURE | 45 |
| 2 | MATERNAL EXPOSURE DURING PREGNANCY | 11 |
| 3 | CEREBRAL HAEMORRHAGE FOETAL | 9 |
| 4 | SCHIZENCEPHALY | 9 |
| 5 | HYPOTENSION | 8 |
| 6 | ABORTION INDUCED | 7 |
| 7 | EXPOSURE DURING PREGNANCY | 7 |
| 8 | FOETAL EXPOSURE DURING PREGNANCY | 7 |
| 9 | OFF LABEL USE | 7 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | SCHIZENCEPHALY | 9 | 0.2000 |
| 1 | CEREBRAL HAEMORRHAGE FOETAL | 9 | 0.1475 |
| 2 | ANTITHROMBIN III DEFICIENCY | 1 | 0.0112 |
| 3 | BONE FORMATION DECREASED | 1 | 0.0063 |
| 4 | BLOOD MAGNESIUM INCREASED | 5 | 0.0055 |
| 5 | SOMNOLENCE NEONATAL | 1 | 0.0051 |
| 6 | XERODERMA | 1 | 0.0037 |
| 7 | HUMAN HERPESVIRUS 6 ENCEPHALITIS | 1 | 0.0035 |
| 8 | THERAPEUTIC PRODUCT EFFECT INCREASED | 3 | 0.0026 |
| 9 | VITAMIN B1 DEFICIENCY | 1 | 0.0023 |